• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 385100
Device Problem Leak/Splash (1354)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/01/2020
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that the bd q-syte luer access split-septum stand-alone device experienced leakage.The following information was provided by the initial reporter: (b)(4) q-syte - the q-syte base was leakage.No photos available.
 
Manufacturer Narrative
The following fields were updated due to additional information: d.10.Device available for eval?: yes.D.10.Returned to manufacturer on: 12/14/2020.H.6.Investigation: our quality engineer inspected the sample submitted for evaluation.Bd received one used q-syte unit which consists of the q-syte only.Through the microscopic evaluation, the unit reveals traces of dried media present on the unit.There is a large tear at one end and at the center of the slit at the septum top disk along with impressions of damage around the slit.There are also large tears at each end of the slit at the septum bottom disk.A leakage test was performed where leakage was not observed from any area of the unit when tested in the unactuated and actuated positions.Although the report of leakage was not confirmed, the damage to the septum was verified.The observed defect could not be determined if the damage resulted from the manufacturing of the device or from the user environment.During manufacturing tear(s) at the top and/or bottom disk can be caused by a damaged, dull or misaligned blade during the septum slit process.Tears to the column wall can occur when the probe enters the slit due to mandrel misalignment.During use, damage to the septum, as seen in the unit, can occur due to excessive actuations and extraneous force.A device history record review showed no non-conformances associated with this issue during the production of this batch.H3 other text : see h.10.
 
Event Description
It was reported that the bd q-syte¿ luer access split-septum stand-alone device experienced leakage.The following information was provided by the initial reporter: 385100-q-syte - the q-syte¿s base was leakage.No photos available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
MDR Report Key11088800
MDR Text Key226858511
Report Number9610847-2020-00433
Device Sequence Number1
Product Code FPA
UDI-Device Identifier00382903851003
UDI-Public00382903851003
Combination Product (y/n)N
PMA/PMN Number
K013621
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 03/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number385100
Device Lot Number0027180
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/14/2020
Initial Date Manufacturer Received 12/01/2020
Initial Date FDA Received12/29/2020
Supplement Dates Manufacturer Received03/08/2021
Supplement Dates FDA Received03/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-